Serum Inhibitor in Systemic Lupus Erythematosus Associated with Aplastic Anemia
Overview
Authors
Affiliations
Hematologic complications of systemic lupus erythematosus (SLE) usually involve peripheral destruction of blood elements. We report a case of SLE-associated aplastic anemia in which an IgG complement-dependent antibody, obtained from the patient's disease-phase serum but not remission-phase serum, suppressed growth of granulocyte-macrophage progenitor cells from bone marrow of normal donors in vitro. Therapy with plasmapheresis and immunosuppression resulted in lasting remission.
Al-Ghazawi Z, Al-Farajat A, Toubasi A, Tawileh H, Qteish A, Aladily T Rheumatol Int. 2024; 44(5):943-953.
PMID: 38512478 DOI: 10.1007/s00296-024-05585-6.
Immune-mediated Coombs negative intravascular haemolysis in systemic lupus erythematosus (SLE).
Magendiran B, Jose A, Kolar Vishwanath V, Bammigatti C BMJ Case Rep. 2021; 14(8).
PMID: 34417246 PMC: 8381295. DOI: 10.1136/bcr-2021-244459.
Anderson E, Shah B, Davidson A, Furie R Semin Arthritis Rheum. 2018; 48(1):90-104.
PMID: 29395255 PMC: 5993585. DOI: 10.1016/j.semarthrit.2017.12.004.
van den Akker M, Silverman E, Abdelhaleem M, Kirby-Allen M Clin Case Rep. 2014; 2(6):319-22.
PMID: 25548637 PMC: 4270717. DOI: 10.1002/ccr3.123.
Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review.
Chalayer E, Ffrench M, Cathebras P Rheumatol Int. 2014; 35(6):1073-82.
PMID: 25354463 DOI: 10.1007/s00296-014-3162-4.